Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biodyn (OBD) Share News

123456

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

23rd May 2024 21:08

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Oxford BioDynamics to provide tests to largest UK charitable hospital

21st May 2024 14:06

(Alliance News) - Oxford BioDynamics PLC on Tuesday announced a new partnership with The London Clinic. Read More

TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal

16th May 2024 20:09

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Oxford BioDynamics reaches "important milestone" with new laboratory

3rd Apr 2024 14:31

(Alliance News) - Oxford BioDynamics PLC said on Wednesday that it has opened a clinical testing laboratory in the UK to perform EpiSwitch prostate screening tests. Read More

TRADING UPDATES: FireAngel CFO resigns; ECR Minerals raises GBP585,000

14th Mar 2024 16:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

13th Mar 2024 20:49

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

CORRECT: Oxford BioDynamics plunges as annual loss widens; revenue up

17th Jan 2024 10:50

(Correcting headline to show loss widened, revenue rose) Read More

CORRECT: Oxford BioDynamics plunge as annual profit rises; revenue up

17th Jan 2024 10:43

(Correcting headline to show profit and revenue rose) Read More

Oxford BioDynamics shares plunge as annual revenue widens; revenue up

17th Jan 2024 10:35

(Alliance News) - Oxford BioDynamics PLC on Wednesday said its full-year loss narrowed, but saw its revenue jump on contracts for EpiSwitch. Read More

AIM WINNERS & LOSERS: James Cropper falls on lower outlook

17th Jan 2024 10:24

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

IN BRIEF: Oxford BioDynamics director sells over 700,000 shares

20th Oct 2023 10:32

Oxford BioDynamics PLC - biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform - Reports that Vulpes Testudo Fund, controlled by Non-Executive Director Stephen Diggle has sold 777,000 shares of one pence each at an average price of 38.3p each. Diggle is now interested in 27.6 million shares in total, through the Vulpes Testudo and Vulpes Life Sciences Funds. These represent approximately 13.62% of Oxford BioDynamics's current issued share capital. Company's market capitalisation is GBP69.79 million. Read More

Oxford BioDynamics in deal with Bupa to expand blood test access

18th Oct 2023 10:25

(Alliance News) - Oxford BioDynamics PLC shares surged on Wednesday as it announced a strategic deal with Bupa UK Insurance to enhance access to a "first-of-its-kind" blood test for cancer patients. Read More

AIM WINNERS & LOSERS: Safestyle plunges as seeks cash injection

3rd Oct 2023 10:21

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

Oxford BioDynamics issued insurance reimbursement code for EpiSwitch

3rd Oct 2023 10:15

(Alliance News) - Oxford BioDynamics PLC on Tuesday said it has been issued an insurance reimbursement code for its EpiSwitch product from the American Medical Association. Read More

Oxford BioDynamics soars as validates prostate test ahead of schedule

26th Sep 2023 17:41

(Alliance News) - Shares in Oxford BioDynamics PLC leapt on Tuesday after it announced the validation of its EpiSwitch prostate screening test in its US clinical laboratory was now complete, ahead of schedule. Read More

UK shareholder meetings calendar - next 7 days

11th Aug 2023 15:44

Read More

Oxford BioDynamics raises GBP540,000 in further equity raise

4th Aug 2023 15:03

(Alliance News) - Oxford BioDynamics PLC on Friday said it raised GBP543,577 after completing its PrimaryBid offer announced on Tuesday. Read More

IN BRIEF: Oxford BioDynamics raises GBP5.6 million through placing

2nd Aug 2023 11:33

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovering and developing epigenetic biomarkers - Raises GBP5.6 million via accelerated bookbuild process and through direct subscription. 48.1 million shares are issued pursuant to the placing at an issue price of 11.0 pence per share. Subscribers have conditionally subscribed for 2.5 million shares at issue price. The placing shares and subscription shares represents around 25% of the company's issued share capital. Shore Capital and Baden Hill acted as joint brokers and bookrunners in connection with the placing. Oxford BioDynamics have applied for shares to be admitted to trading on AIM, and expect this trading to commence on August 21. Read More

Oxford BioDynamics proposes GBP7 million fundraise for EpiSwitch plans

1st Aug 2023 18:16

(Alliance News) - Oxford BioDynamics PLC on Tuesday said it plans to raise GBP7 million via a placing, subscription and retail offer of new shares in the company. Read More

AIM WINNERS & LOSERS: Empire Metals surges on Pitfield results

30th May 2023 10:31

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

123456
FTSE 100 Latest
Value9,310.27
Change1.07